EMAS promotes the study of midlife health through its journal, congresses, schools, webinars and website and encourages the exchange of research and professional experience between members.

Using a range of activities and through its affiliates, EMAS aims to guarantee and provide the same standard of education and information throughout Europe on midlife health in both genders.

EMAS promotes the study of midlife health through its journal, congresses, schools and website and encourages the exchange of research and professional experience between members.
Using a range of activities and through its affiliates, EMAS aims to guarantee and provide the same standard of education and information throughout Europe on midlife health in both genders. Recognizing the issues arising from increased longevity the society alsoprovides articles, patient information, web resources, and referrals for healthcare providers in the field and keeps its members up-to-date.

Join EMAS and receive a variety of benefits
Subscription to the MATURITAS - the European Menopause Journal, the official organ of the European Menopause and Andropause.
Monthly alerts on the content of the Maturitas journal Reduced registration fees to all EMAS Congresses.
As a National Menopause Society, affiliated to EMAS, you may organise your annual meetings under the auspices of EMAS.
EMAS assists national societies in planning and organising such meetings and provide information on planned European activities on midlife health issues.

EMAS Junior Mentorship Programme (JuMP) 2017-2019
Click here for more information:

Maturitas is an international multidisciplinary peer reviewed scientific journal of midlife health and beyond publishing original research, reviews, consensus statements and guidelines. Published by Elsevier Science.

Impact Factor 2016  3.255
Article Usage 2016
Maturitas.org: 288,274 downloads
ClinicalKey: 31,643 downloads
ScienceDirect: 521,662 downloads
841,579 Total Article Downloads
Submission to First Decision2.6 weeks
Submission to Final Decision 4.2 weeks